drugset

drugset / Trial / NCT07166887

Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male

NCT07166887 ↗

Phase 1 Completed 12 enrolled Otsuka Beijing Research Institute

NaSingle-groupOpen-labelTreatment

Summary

pharmacokinetics, pharmacological effects and safety of multi dose of 7.5mg Tolvaptan tablet in healthy male subjects

Timeline

Start: 2011-06-07
Primary completion: 2011-07-27
Completion: 2011-07-27

Publications

Liu H, Liu T, Liu M, Zheng X, Zhong W, Zhao Q, Jiang J, Hu P, Li Y. Clinical trial on the pharmacokinetics, pharmacodynamics and safety of tolvaptan in healthy Chinese males: an open-label, single and multiple dosage, parallel group study. Front Pharmacol. 2025 Nov 21;16:1713702. doi: 10.3389/fphar.2025.1713702. eCollection 2025.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tolvaptan	Small molecule	7.5 mg	Oral

Indications

No indication recorded.